The FDA has approved the first all-oral, fixed-duration first-line regimen for treatment of chronic lymphocytic leukemia and small lymphocytic lymphoma.Acalabrutinib (Calquence, AstraZeneca) tablets ...

Lori A. Leslie, MD, and Hoshiyuki Iida, APN, provide an overview of chronic lymphocytic leukemia and the risk stratification process. Lori A. Leslie, MD: Hello, and welcome to CURE Expert Connections® ...

AstraZeneca’s CALQUENCE® (acalabrutinib) in combination with venetoclax has been approved in the US as the first all-oral, fixed-duration regimen for the treatment of adult patients with chronic ...

Randomized Controlled Trial of Collaborative Care Management of Depression Among Low-Income Patients With Cancer Chronic lymphocytic leukemia (CLL) has unique epidemiologic, biologic, and clinical ...

The most commonly used staging systems worldwide are Rai and Binet, since both are both simple, inexpensive, and easy to use. Staging systems cannot differentiate individuals who will have progressive ...

In " Beyond Diagnosis: CLL," Cleveland Clinic hematologist/oncologist Allison Winter, MD, and host John Mangels explore how ...

Genetic predisposition and lifestyle factors both play crucial roles in diabetes management and onset. Cancer treatment can complicate diabetes management, requiring careful coordination between ...

Cancer that forms in blood and bone marrow is called chronic lymphocytic leukemia (CLL). In chronic lymphocytic leukemia, the word “chronic” denotes slow progress and the word "lymphocytic" means ...

Acute Lymphocytic Leukemia (ALL) is a serious type of cancer that affects the blood and bone marrow. It moves very quickly, meaning it needs fast and strong treatment. In ALL, the body starts making ...

Phase 1/2 studies of DZD8586 in CLL/SLL patients after covalent or non-covalent BTK inhibitors and BTK degraders. This is an ASCO Meeting Abstract from the 2025 ASCO Annual Meeting I. This abstract ...